References

• 2003The price of innovation: new estimates of drug development costs4,264 cited
• 2000Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not)3,045 cited
• 1998Can Patents Deter Innovation? The Anticommons in Biomedical Research2,575 cited
• 1998The Tragedy of the Anticommons: Property in the Transition from Marx to Markets1,344 cited
• 1991Standing on the Shoulders of Giants: Cumulative Research and the Patent Law1,303 cited
• 1994The Importance of Patent Scope: An Empirical Analysis1,212 cited
• 1990On the Complex Economics of Patent Scope939 cited
• 1986Patents and innovation: an empirical study854 cited
• 2003The market economy, and the scientific commons756 cited
• 1977The Nature and Function of the Patent System705 cited
• 1995On the Division of Profit in Sequential Innovation691 cited
• 2011Innovation and Its Discontents678 cited
• 2000The U.S. patent system in transition: policy innovation and the innovation process646 cited
• 2004Key factors in the rising cost of new drug discovery and development499 cited
• 2001Rational Ignorance at the Patent Office376 cited